Daphna Laifenfeld News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer s Disease

CAMBRIDGE, Mass., April 22, 2024 /PRNewswire/ NeuroSense Therapeutics Ltd. , a company developing novel treatments for severe neurodegenerative diseases announced today a collaboration in.

United kingdomNeurosense primeShiran zimriTalia cohen solalNeurosense therapeutics ltdRambam health care campusExchange commissionCognition instituteExchange commission onNeurosense therapeuticsDaphna laifenfeldSense therapeuticsNeurosense therapeuticAnnual report

Clexio and Genetika+ announce partnership using proprietary antidepressant screening platform

TEL AVIV and PETAH TIKVA, Israel, Feb. 6, 2023 /PRNewswire/ As part of a shared commitment to bring better solutions for people suffering from depression, Clexio and Genetika+ are partnering

Clexio biosciencesElisabeth koganTalia cohen solalSchwierige zeitenMichael falconeMajor depressive disorderDaphna laifenfeld

Genetika+ Wins Prestigious European Funding to Bring Depression Drug Matching Platform to Market

Genetika+ Wins Prestigious European Funding to Bring Depression Drug Matching Platform to Market
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Talia cohen solalMichael falconeEuropean commission innovation councilEuropean commissionEuropean innovation councilInnovation councilDaphna laifenfeld

Israeli research institute makes great contributions to cancer research

Technologies including artificial intelligence-based diagnostic software may be changing how the disease is detected and treated in the future.

United kingdomMarcelle machlufYuval shakedBreakthrough devices programNational healthcare systemDrug administrationIbex medicalDaphna laifenfeldChief scientificProfessor marcelle machluf

Genetika+ CEO Talia Cohen Solal Brings Precision Medicine to Brain Health

Depression is the first indication, but other neurological conditions are being planned.

New yorkUnited statesIsrael generalColumbia universityHarvard universityCohen solalTalia cohen solalUniversity college londonHealth israelXtreme healthOxford universityCo founder talia cohenDaphna laifenfeldXtreme health challengeAvon product women startupEnetika ceo talia cohen solal brings precision medicine to brain health